Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc.
Your view on ZBH
Overview
What the company does, where it operates, and who runs it.
About Zimmer Biomet Holdings, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Ivan Tornos
- Headquarters
- 345 East Main Street, Warsaw, IN, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Ivan Tornos
- Headquarters
- 345 East Main Street, Warsaw, IN, US
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T.
products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.
It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues.
It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015.
Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Zimmer Biomet Holdings, Inc. from FRC's valuation model, read against the market price. ZBH last traded at $101.41, 25.6× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Zimmer Biomet Holdings, Inc.. Starting points for Zimmer Biomet Holdings, Inc.: P/E 25.6, EPS $4.03, beta 0.47 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Zimmer Biomet Holdings, Inc.. Zimmer Biomet Holdings, Inc. paid $0.96 per share over the last year — a 0.9% yield at the current $101.41 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Zimmer Biomet Holdings, Inc.. Trailing twelve-month EPS for Zimmer Biomet Holdings, Inc. stands at $4.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$109.77
average of 13 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy6
- Hold11
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $2.49 | $2.08 | $8.55 | $8.98 |
| Low estimate | $2.46 | $2.03 | $8.53 | $8.76 |
| High estimate | $2.52 | $2.15 | $8.56 | $9.13 |
| No. of analysts | 16 | 11 | 16 | 16 |
| Year-ago EPS | $2.42 | $2.09 | $3.551 | — |
| Growth | +3.1% | -0.7% | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $2.29B | $2.15B | $8.61B | $8.90B |
| Low estimate | $2.28B | $2.12B | $8.60B | $8.82B |
| High estimate | $2.30B | $2.18B | $8.63B | $8.98B |
| No. of analysts | 15 | 9 | 19 | 19 |
| Year-ago revenue | $2.24B | $2.09B | $8.23B | — |
| Growth | +2.0% | +2.9% | +4.7% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Zimmer Biomet Holdings, Inc.. Zimmer Biomet Holdings, Inc. has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- ALGNAlign Technology, Inc.Medical - Devices$11.7B
- BSXBoston Scientific CorporationMedical - Devices$63.3B
- EWEdwards Lifesciences CorporationMedical - Devices$61.6B
- GEHCGE HealthCare Technologies Inc.Medical - Devices$37.5B
- MDTMedtronic plcMedical - Devices$131.6B
- OFIXOrthofix Medical Inc.Medical - Devices$277M
- PHGKoninklijke Philips N.V.Medical - Devices$29.3B
- SNNSmith & Nephew plcMedical - Devices$13.0B
More Medical - Devices companies
- ARX.AXAroa Biosurgery LimitedASX
- ASAPFAurora Spine CorporationOTC$16M
- ASG.VAurora Spine CorporationTSXV$16M
- ASTI.CNAquarius Surgical Technologies Inc.CNQ
- AT1.AXAtomo Diagnostics LimitedASX
- ATECAlphatec Holdings, Inc.NASDAQ$1.1B
- AVH.AXAVITA Medical, Inc.ASX
- AVHHLAVITA Medical, Inc.OTC$99M
- AVRAnteris Technologies Global Corp.NASDAQ$556M
- AVR.AXAnteris Technologies LtdASX
- AXGNAxoGen, Inc.NASDAQ$3.3B
- BBNXBeta Bionics, Inc.NASDAQ$684M
ETFs holding Zimmer Biomet Holdings, Inc.
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.03%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.02%
- VBVanguard Small-Cap ETF$76.9B in assets0.22%
- MOATVanEck Morningstar Wide Moat ETF$11.9B in assets2.66%
- OAKMOakmark U.S. Large Cap ETF$1.2B in assets2.65%
- FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets2.65%
- IHIiShares US Medical Devices ETF$4.0B in assets2.46%
- FTAFirst Trust Large Cap Value AlphaDEX Fund$1.5B in assets0.77%
Largest holders first, then the funds most concentrated in ZBH.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Zimmer Biomet Holdings, Inc., and how their positions are changing. At a $19.19B market value, institutional positions materially move Zimmer Biomet Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Zimmer Biomet Holdings, Inc. executives and directors. Shares of Zimmer Biomet Holdings, Inc. have traded between $85.33 and $114.44 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Zimmer Biomet Holdings, Inc.. Zimmer Biomet Holdings, Inc. is a $19.19B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Zimmer Biomet Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Zimmer Biomet Holdings, Inc.. Coverage tracks Zimmer Biomet Holdings, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Zimmer Biomet Holdings, Inc.